Arcadia Biosciences earnings date
Arcadia Biosciences (17D) Q1 2025 Earnings Report
DE:17D Q1 2025 EPS Results
- Actual EPS
- EUR 1.73
- Consensus EPS
- -EUR 0.89
- Beat/Miss
- Beat by +EUR 2.62
- One Year Ago EPS
- -EUR 1.62
DE:17D Q1 2025 Revenue Results
- Actual Revenue
- EUR 1.09M
- Expected Revenue
- EUR 1.18M
- Beat/Miss
- Missed by -EUR 90.95K
- YoY Revenue Growth
- -4.38%
Earnings Announcement Details
- Quarter
- Q1 2025
- Date
- 05/08/2025
- Time
- Before Open
- Conference Call
- Thursday, May 8, 2025
Arcadia Biosciences's next earnings date is estimated for April 1, 2027, based on past reporting schedules.
Q1 2025 Earnings Call Audio
Q1 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2025 Earnings Call Summary
The earnings call reflected a strong start to 2025, with significant revenue growth in the Zola brand and effective cost control measures. However, challenges such as a decline in gross margin and an increase in inventory and cash consumption were noted. The pending business combination with Roosevelt Resources is a positive development, enhancing future prospects.
During the Arcadia Biosciences, Inc. first-quarter 2025 conference call, significant growth and strategic shifts were highlighted. The company reported a remarkable 90% year-over-year increase in revenue for its Zola coconut water, primarily due to a 70% rise in new distribution channels. Operating expenses saw a 16% reduction, despite incurring nearly half a million dollars in transaction-related fees. The gross margin stood at 43%, maintaining a trend of exceeding 30% for nine consecutive quarters. Arcadia continued to monetize its intellectual property, securing $750,000 in cash for certain soy patents, which allowed for the elimination of a $1,000,000 contingent liability. The pending business combination with Roosevelt Resources is progressing, aiming for completion by late summer, with a fixed equity share ratio of 90-10 between Roosevelt Partners and Arcadia stockholders. The call also mentioned a strong pipeline and new product innovations expected to further boost Zola's market presence. Overall, the company is focused on streamlining operations and enhancing financial performance in 2025.
- Zola Revenue GrowthZola coconut water revenue grew 90% year-over-year, driven by a 70% increase in new distribution gains.
- Strong Pipeline and Distribution ExpansionZola is in discussions with new customers and distributors, representing more than 50% of its current customer base, and has already won new customer accounts in Q2.
- Cost Control and Operating Expense ReductionOperating expenses were reduced by 16% year-over-year, inclusive of transaction-related fees.
- Monetization of Intellectual PropertyArcadia entered an agreement with BioSeries, resulting in $750,000 in cash and the elimination of a $1,000,000 contingent liability from the balance sheet.
- Pending Business CombinationThe business combination with Roosevelt Resources is on track to be completed by the end of the summer, providing Arcadia stockholders with a greater level of ownership certainty post-transaction.
DE:17D Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 01, 2027 | 2026 (Q4) | ―- | -1.92 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | ―0.26 | -0.77 | 134.20% (+1.04) | |
| Aug 13, 2026 | 2026 (Q2) | ―-1.90 | -2.97 | 35.89% (+1.06) | |
| May 14, 2026 | 2026 (Q1) | ―-1.92 | 1.73 | -211.05% (-3.65) | |
| Mar 26, 2026 | 2025 (Q4) | -0.60-0.88 | -2.71 | 67.45% (+1.83) | |
| Nov 07, 2025 | 2025 (Q3) | -0.49-0.77 | -1.07 | 28.14% (+0.30) | |
| Aug 14, 2025 | 2025 (Q2) | -0.72-2.97 | 0.71 | -517.95% (-3.67) | |
| May 08, 2025 | 2025 (Q1) | -0.891.73 | -1.62 | 206.74% (+3.35) | |
| Mar 20, 2025 | 2024 (Q4) | -0.81-2.71 | -1.91 | -41.90% (-0.80) | |
| Nov 12, 2024 | 2024 (Q3) | -0.74-1.07 | -1.72 | 37.57% (+0.65) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

